Quantum Satis SRL
The score of Quantum Satis shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +222 % Total assets +38 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Quantum Satis's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 25 Jul 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 06 Jul 2022
Quantum Satis's financial analysis
- Solvency56.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Quantum Satis
Quantum Satis's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0778.485.079
- VAT number
- BE0778485079
- Peppol
- Registered · 0208:0778485079 · as of 03 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Dec 2021
- Registered office
- 9240 Zele
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Quantum Satis (SRL) has been based in Zele since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 4,635 € and equity of 19,377 €; its revenue is not published. Its solvency stands at 56.5%, above the median of its sector (44.2%).
Companies similar to Quantum Satis
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- LEJV Retail sale of pharmaceutical products Bertrix · balance sheet 34,528 €
- DEL Pharma Retail sale of pharmaceutical products Mons · balance sheet 36,943 €
- Pharmacycle Retail sale of pharmaceutical products Brussels · balance sheet 41,191 €
- Kephas Pharma Retail sale of pharmaceutical products Pont-à-Celles · balance sheet 57,577 €
- Siga Pharm Retail sale of pharmaceutical products Uccle · balance sheet 46,193 €
- Vanfleteren Pieter Retail sale of pharmaceutical products Antwerp · balance sheet 52,894 €
- Helephar Retail sale of pharmaceutical products Wingene · balance sheet 55,332 €
Frequently asked questions about Quantum Satis
What is the revenue of Quantum Satis?
Quantum Satis files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Quantum Satis?
In Belgium, the VAT number is the company number prefixed with BE: BE0778485079 for Quantum Satis, if the company is VAT-registered. Its company number (CBE) is 0778.485.079.
Where is the registered office of Quantum Satis?
According to the CBE register, the registered office of Quantum Satis is in 9240 Zele.
What is the equity of Quantum Satis?
At the close of the 2025 financial year, the equity of Quantum Satis amounts to 19,377 €, a solvency of 56.5% of total assets.
Who manages Quantum Satis?
The register lists 1 active mandates at Quantum Satis. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Quantum Satis
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →